(Q43037298)

12 November 2017

title

Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo (English)

1 reference

12 November 2017

1 reference

1 reference

19

Kazuaki Chayama

1 reference

12 November 2017

2

Michio Imamura

1 reference

12 November 2017

7

Masataka Tsuge

1 reference

12 November 2017

8

Shoichi Takahashi

1 reference

12 November 2017

18

Shinji Tanaka

1 reference

12 November 2017

9

Hidenori Ochi

1 reference

12 November 2017

4

C Nelson Hayes

1 reference

12 November 2017

1

Nobuhiko Hiraga

1 reference

12 November 2017

13

Chise Tateno

1 reference

12 November 2017

14

Katsutoshi Yoshizato

1 reference

12 November 2017

10

Eiji Iwao

1 reference

12 November 2017

11

Naohiro Kamiya

1 reference

12 November 2017

12

Ichimaro Yamada

1 reference

12 November 2017

6

Mayu Onishi

1 reference

12 November 2017

Hiromi Abe

3

1 reference

12 November 2017

Tomohiko Kono

5

1 reference

12 November 2017

Hirotaka Matsui

15

1 reference

12 November 2017

Akinori Kanai

16

1 reference

12 November 2017

Toshiya Inaba

17

1 reference

12 November 2017

language of work or name

English

0 references

publication date

2 August 2011

1 reference

12 November 2017

1 reference

12 November 2017

volume

54

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

781-788

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

12 November 2017

cites work

1 reference

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

21 January 2018

1 reference

Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease

21 January 2018

1 reference

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

21 January 2018

1 reference

Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro

21 January 2018

1 reference

Replication of hepatitis C virus

21 January 2018

1 reference

Rapid emergence of protease inhibitor resistance in hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

21 January 2018

1 reference

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor

21 January 2018

1 reference

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.

21 January 2018

1 reference

Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice

21 January 2018

1 reference

Near completely humanized liver in mice shows human-type metabolic responses to drugs

21 January 2018

1 reference

Multiplex sequencing of plant chloroplast genomes using Solexa sequencing-by-synthesis technology

21 January 2018

1 reference

Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.

21 January 2018

1 reference

Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

21 January 2018

1 reference

Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations.

21 January 2018

1 reference

Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing

21 January 2018

1 reference

Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing

21 January 2018

1 reference

Hepatitis C virus transmission bottlenecks analyzed by deep sequencing.

21 January 2018

1 reference

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

21 January 2018

1 reference

ABySS: a parallel assembler for short read sequence data

21 January 2018

1 reference

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir

21 January 2018

1 reference

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

21 January 2018

1 reference

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus

21 January 2018

1 reference

Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759

21 January 2018

1 reference

Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.24460

1 reference

12 November 2017

1 reference